Literature DB >> 29116253

Testicular cancer: No activity of pembrolizumab in phase II trial.

Clemens Thoma.   

Abstract

Entities:  

Year:  2017        PMID： 29116253     DOI： 10.1038/nrurol.2017.194

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206.

Authors:  N Adra; L H Einhorn; S K Althouse; N R Ammakkanavar; D Musapatika; C Albany; D Vaughn; N H Hanna
Journal:  Ann Oncol       Date:  2018-01-01       Impact factor: 32.976
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.